EichorEICHOR
Study identifier: NCT07168902 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Condition: Glaucoma  ·  Sponsor: Bausch & Lomb Incorporated

PhasePhase 2
Planned participants252
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (14)

Global Research Management, Inc.Glendale, California, United States
Eye Research FoundationNewport Beach, California, United States
California Eye Specialist Medical Group, LLCPasadena, California, United States
Eye Associates of Fort MyersFort Myers, Florida, United States
Levenson Eye AssociatesJacksonville, Florida, United States
Central Florida Eye AssociatesLakeland, Florida, United States
Lee Shettle Eye and HearingLargo, Florida, United States
Clayton Eye Clinical Research, LLCMorrow, Georgia, United States
Coastal Research Associates, LLCRoswell, Georgia, United States
Heart of America Eye CareShawnee Mission, Kansas, United States
Andover Eye AssociatesAndover, Massachusetts, United States
Scott & Christie and Associates, PCCranberry Township, Pennsylvania, United States

+ 2 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →